β3-AR stimulation regulated the expression of peroxisome proliferator-activated receptors (PPARs)/mCPT-1 and FAT/CD36, ameliorated liver lipid accumulation, and helped alleviate liver steatosis in NAFLD (Fig. 5). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.